ClariTrial — AI Clinical Trial Intelligence

Pneumococcal conjugate vaccine GSK1024850AGSK Biologicals' Engerix TM vaccine (Hepatitis B vaccine)GSK Biologicals' Havrix TM vaccine (Hepatitis A vaccine)

GlaxoSmithKline41,188 participants1 site · FinlandCompletes Jan 2012

CT.gov Full analysis →

1–15 of 172

Explore/antimicrobial resistance novel antibiotic clinical trials Phase 2 Phase 3

Status

Phase

172 results for “antimicrobial resistance novel antibiotic clinical trials Phase 2 Phase 3”

Page 1 of 12

NCT02409290

Completed

Results posted

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

Phase 3MDR-TB

Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)MoxifloxacinClofazimine+7 more

IUATLD, Inc588 participants13 sites · Ethiopia, Georgia, IndiaCompletes May 2022

CT.gov Full analysis →

NCT01638520

UNKNOWN

Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis

Phase 2Tuberculosis, Pulmonary

PascolizumabPlacebo

National University Hospital, Singapore32 participants7 sites · Malaysia, Philippines, SingaporeCompletes Feb 2017

CT.gov Full analysis →

NCT03317093

Completed

Open and Exploratory Trial to Investigate the Pharmacokinetic of Ceftobiprole Medocaril in Patients With CSF Device

Phase 2Inflamed MeningesSuspected MeningitisVentriculitis

Ceftobiprole MedocarilBlood samples and cerebrospinal fluid

Centre Hospitalier Universitaire Dijon5 participants1 site · FranceCompletes Oct 2019

CT.gov Full analysis →

NCT03198507

Completed

Results posted

ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator

Phase 3Helicobacter Pylori InfectionDyspepsia

RHB-105Active Comparator

RedHill Biopharma Limited455 participants55 sites · United StatesCompletes Oct 2018

CT.gov Full analysis →

NCT03543436

Completed

Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections

Phase 3Urinary Tract Infections

Temocillinmeropenem or imipenem

Assistance Publique - Hôpitaux de Paris29 participants16 sites · FranceCompletes Oct 2020

CT.gov Full analysis →

NCT03358576

Completed

Results posted

Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)

Phase 3Intra Abdominal Infections

ErtapenemSulopenem-Etzadroxil/ProbenecidCiprofloxacin+3 more

Iterum Therapeutics, International Limited674 participants42 sites · United States, Bulgaria, EstoniaCompletes Oct 2019

CT.gov Full analysis →

NCT06925386

Not Yet Recruiting

The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment

Phase 2Acne Vulgaris

Standard therapyHEXBIOSecretome

Universitas Padjadjaran64 participants1 site · IndonesiaCompletes Dec 2025

CT.gov Full analysis →

NCT03117751

Active

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

Phase 2Phase 3Acute Lymphoblastic LeukemiaAcute Lymphoblastic Lymphoma

PrednisoneVincristineDaunorubicin+20 more

St. Jude Children's Research Hospital790 participants8 sites · United States, AustraliaCompletes Sep 2026

CT.gov Full analysis →

NCT03673956

Completed

Results posted

Topical Antibiotics in Chronic Rhinosinusitis

Phase 1Phase 2Chronic Rhinosinusitis (Diagnosis)

MupirocinTobramycinLevofloxacin+1 more

Mayo Clinic19 participants1 site · United StatesCompletes Feb 2021

CT.gov Full analysis →

NCT01404312

Completed

Results posted

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

Phase 3TuberculosisHIV Infections

Rifapentine (RPT)Isoniazid (INH)Pyridoxine (Vitamin B6)

National Institute of Allergy and Infectious Diseases (NIAID)3,000 participants45 sites · United States, Botswana, BrazilCompletes Nov 2017

CT.gov Full analysis →

NCT03537495

Completed

Pharmacokinetic Study of Linezolid for TB Meningitis

Phase 2Tuberculosis, MeningealLinezolid

Linezolid

Universitas Padjadjaran36 participants1 site · IndonesiaCompletes Mar 2023

CT.gov Full analysis →

NCT00216346

Completed

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

Phase 3Visceral Leishmaniasis

Paromomycin sulfateAmphotericin B

PATH667 participants4 sites · India

CT.gov Full analysis →

NCT07194941

Completed

Efficacy and Safety of Fecal Microbiota Transfer (FMT) for Recurrent Urinary Tract Infections in Women

Phase 2Recurrent Urinary Tract Infections in Women

Freeze-dried product made of fresh feces

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal40 participants1 site · SpainCompletes Feb 2025

CT.gov Full analysis →

NCT00405704

Completed

Results posted

Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)

Phase 3Vesicoureteral RefluxUrinary Tract Infections

Trimethoprim-SulfamethoxazolePlacebo

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)607 participants19 sites · United StatesCompletes Jun 2013

CT.gov Full analysis →

NCT00861380

Completed

Results posted

Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease

Phase 3Infections, StreptococcalStreptococcus Pneumoniae

Pneumococcal conjugate vaccine GSK1024850AGSK Biologicals' Engerix TM vaccine (Hepatitis B vaccine)GSK Biologicals' Havrix TM vaccine (Hepatitis A vaccine)

GlaxoSmithKline41,188 participants1 site · FinlandCompletes Jan 2012

CT.gov Full analysis →

1–15 of 172